In 2024 a proposed service agreement covered six thousand devices across a customer group. The headline volume was commercially attractive, but the review established verified support scope for 2,200; 3,800 remained outside it. The distinction involved the relevant permissions, competence and support arrangements, not merely a decision to allocate more staff. Commercial colleagues wanted the broad agreement because it could simplify the customer's buying process. Technical colleagues warned that the contract wording could make the business appear responsible for equipment it was not ready or authorised to support.
I supported a narrower proposal covering the 2,200 devices within the verified scope. The other 3,800 were explicitly outside the agreement rather than treated as a future capability already included in the price. The customer and the authorised teams needed a clear account of those boundaries and their remaining arrangements. Strategy did not decide that a device was suitable for clinical use, prescribe a repair method or replace the customer's own responsibilities. The agreement had to reflect the support position established by the qualified teams.
The narrower scope reduced the immediate commercial opportunity and removed the appeal of a single all-device contract. We accepted that limitation instead of assuming the missing support could be assembled after signature. The case does not state that no additional device could ever be brought into scope. It states that the evidence available for this proposal supported 2,200, and that the agreement should not imply otherwise. Any expansion would need its own review and agreement rather than rely on the ambition of the initial presentation.
My contribution was to make the strategic account smaller and more operable. A contract can be valuable because its boundaries are understood, even when the headline is less impressive than the opportunity first discussed. I retained the 3,800 exclusions in the narrative so a reader could see what we gave up. No uptime improvement, repair outcome or clinical benefit is inferred from the act of signing. The decision concerned the service commitment the enterprise could responsibly make at that point.